Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow-to-Debt Ratio
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $360.04 Billion could theoretically repay 0% of its total liabilities ($7.77 Trillion) in one year. See Takeda Pharmaceutical Co Ltd ADR (TAK) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Takeda Pharmaceutical Co Ltd ADR Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Also explore TAK net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Takeda Pharmaceutical Co Ltd ADR (2001–2025)
Year-by-year debt coverage analysis for Takeda Pharmaceutical Co Ltd ADR. For market capitalisation and broader financial context, see TAK company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $1.06 Trillion | $7.31 Trillion | ▲ +58.1% |
| 2024 | 0.09x | $716.34 Billion | $7.83 Trillion | ▼ -28.9% |
| 2023 | 0.13x | $977.16 Billion | $7.60 Trillion | ▼ -14.2% |
| 2022 | 0.15x | $1.12 Trillion | $7.49 Trillion | ▲ +14.7% |
| 2021 | 0.13x | $1.01 Trillion | $7.74 Trillion | ▲ +57.9% |
| 2020 | 0.08x | $669.75 Billion | $8.09 Trillion | ▲ +119.4% |
| 2019 | 0.04x | $328.48 Billion | $8.71 Trillion | ▼ -79.1% |
| 2018 | 0.18x | $377.85 Billion | $2.09 Trillion | ▲ +66.6% |
| 2017 | 0.11x | $261.36 Billion | $2.41 Trillion | ▲ +672.3% |
| 2016 | 0.01x | $25.49 Billion | $1.81 Trillion | ▼ -83.9% |
| 2015 | 0.09x | $182.52 Billion | $2.09 Trillion | ▲ +19.4% |
| 2014 | 0.07x | $148.34 Billion | $2.03 Trillion | ▼ -58.8% |
| 2013 | 0.18x | $307.71 Billion | $1.73 Trillion | ▼ -20.6% |
| 2012 | 0.22x | $336.57 Billion | $1.51 Trillion | ▼ -55.6% |
| 2011 | 0.50x | $326.94 Billion | $649.75 Billion | ▼ -13.1% |
| 2010 | 0.58x | $381.17 Billion | $658.53 Billion | ▲ +25.3% |
| 2009 | 0.46x | $326.27 Billion | $706.35 Billion | ▼ -16.8% |
| 2008 | 0.56x | $292.50 Billion | $526.75 Billion | ▲ +62.2% |
| 2007 | 0.34x | $209.28 Billion | $611.38 Billion | ▼ -36.4% |
| 2006 | 0.54x | $373.57 Billion | $693.87 Billion | ▼ -0.9% |
| 2005 | 0.54x | $295.54 Billion | $544.02 Billion | ▼ -3.2% |
| 2004 | 0.56x | $311.12 Billion | $554.65 Billion | ▲ +4.7% |
| 2003 | 0.54x | $263.45 Billion | $491.64 Billion | ▲ +12.7% |
| 2002 | 0.48x | $240.59 Billion | $505.88 Billion | ▲ +11.3% |
| 2001 | 0.43x | $212.66 Billion | $497.69 Billion | — |